Skip to navigation Skip to main content Skip to footer

Future data release timelines

Provisional timeline for future data releases

The tables below gives details of upcoming data releases and estimated dates for when each release will take place. 

Please be aware that due to the current COVID-19 pandemic UK Biobank's priorities for future data availability are under constant review and timelines are subject to change.

Type of data


Approximate release date

Olink Proteomics phase one data (56k) Proteomic assay data for 56,000 participants covering 1,500 proteins. This includes participants from the case-control study, who attended pre- and post- COVID infection. March 2023
Death Registry Data An update to the death registry data for England, Scotland & Wales on the Data Portal and in Showcase fields. March 2023
Cancer Registry Data An update to the cancer registry data for England, Scotland & Wales on Showcase. March 2023
Hospital Inpatient Data (England and Scotland) Hospital inpatient data for England & Scotland on the Data Portal, with summary fields on Showcase. March 2023
Hospital Inpatient Data (Wales) An update to the Welsh inpatient data to cover the period since February 2018, and to complete the diagnosis data since 2016. March 2023
Scottish psychiatry data An update to the inpatient data for Scotland to include psychiatric admissions. March 2023
OMOP transformation of  dataset We are releasing a transformation of the core dataset and linked healthcare records to OMOP format, which was produced in 2021. March 2023
DXA data An update to the existing DXA data fields in Category 103 covering body composition, bone size, and mineral density assessed by DXA imaging. March 2023
Covid-19 PCR Test Results An update to the existing Covid-19 test result data for England, Scotland & Wales on the Data Portal. July 2023
Covid-19 vaccination data Vaccination data for England, Scotland & Wales. The English data will be available for Covid-19 research only. July 2023
Nightingale Second Phase Data (300k) An additional tranche of NMR metabolomic data produced by Nightingale Health will be released for up to 300,000 participants. July 2023
Health and Well-being Questionnaire Data on participants’ current general health and well-being in light of the COVID-19 pandemic, including a range of common physical and mental health symptoms. July 2023
Integrated HHV-6 data (500k) Data on inherited chromosomally-integrated human herpes virus-6 (HHV-6) available for all 500,000 participants. November 2023
Enhanced Cancer Data ​​Data on cancer stage, grade and other prognostic indicators, and details on cancer treatment modalities. Late 2023
WGS Main Whole Genome Sequencing Release (500k) The final tranche of individual-level and joint-called WGS data for all 500,000 participants. Late 2023
Markers of brain inflammation and neurodegeneration (2.5k) Data from ~1,200 participants (600 cases and 600 matched controls) from the COVID case-control study on circulating levels of neurofilament light protein (NfL), amyloid beta40, amyloid beta42, glial fibrillary acid protein (GFAP) and phosphorylated tau (ptau181) taken at 2 time points, before and after SARS-CoV-2 infection. Late 2023
Olink proteomics Phase 2 Data (60k) Expanded proteomic data covering 3,000 proteins (up from the initial 1,500 proteins measured for the 56,000 participants included in phase 1). This tranche of data will also include the 2,000 participants from the COVID case-control study, with data available before and after SARS-CoV-2 infection. Late 2023
Residential location data Improved (i.e. corrected) and updated data on residential location will be made available, together with other derived location measures, including Lower Super Output Area and Local Authority Area. 2023
Cognitive Function Questionnaire Data from four cognitive function tests which aim to assess cognitive domains such as visual attention, processing speed and non-verbal reasoning.  2023
Mental Well-being Questionnaire Data from the second Mental Well-being Questionniare, comprising a repeat of some of the questions asked in 2016, and an exploration of further issues related to mental health and distress (such as living conditions and social engagement).  2023


Last updated